There is no 100% consensus for reform in the US

Although there is much talk of US patent reform at the moment, it is worth remembering that not everyone is keen for it to happen. This blog has already had a look at the differences that exist between the large high-tech and pharma companies over…

Get unlimited access to all IAM content